With the emergence of immunotherapies and solid tumors, there is a need for more effective approaches to clinical trial design and evaluation. Innovative trial designs and advanced imaging modalities could help optimize outcomes for patients with solid tumors.
In an Applied Clinical Trials article, we discuss the challenges of early phase, solid tumor clinical trials and how we can leverage approaches to improve patient outcomes.
